Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol R Reed

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Clinical Psychiatry|April 30, 2011
A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorderArif Khan, Andrew J Cutler, Daniel K Kajdasz, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose responseDeepak Voora, Svati H Shah, Carol R Reed, et al.
JMIR Formative Research|February 9, 2024
Investigation of the Impact of Wellinks on the Quality of Life and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease: Interventional Research StudyKerri A Pierz, Nicholas Locantore, Gretchen McCreary, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosisMaria C Athanasiou, Michael Dettling, Ingolf Cascorbi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Clinical Psychiatry|April 30, 2011
A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorderArif Khan, Andrew J Cutler, Daniel K Kajdasz, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose responseDeepak Voora, Svati H Shah, Carol R Reed, et al.
JMIR Formative Research|February 9, 2024
Investigation of the Impact of Wellinks on the Quality of Life and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease: Interventional Research StudyKerri A Pierz, Nicholas Locantore, Gretchen McCreary, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosisMaria C Athanasiou, Michael Dettling, Ingolf Cascorbi, et al.
Pageof 2